Livalo Contraindications

(Don't administer to the following patients): Patients with a history of hypersensitivity to any of the components of this product.
Patients with severe hepatic disorders or biliary atresia [In these patients, plasma concentration of this product rises, and the frequency of the occurrence of adverse reactions may increase. In addition, hepatic disorders may be aggravated]. (See Pharmacology: Pharmacokinetics under Actions.)
Patients receiving cyclosporine [Plasma concentration of this product rises, and the frequency of the occurrence of adverse reactions may increase. In addition, severe adverse reactions such as rhabdomyolysis may occur]. (See Interactions and Pharmacology: Pharmacokinetics under Actions.)
Pregnant women, women suspected of being pregnant, or lactating women (see Use in Pregnancy & Lactation).
Relative Contraindications (As a general rule, the co-administration of this product is contraindicated in the following situation. If the use of this product is considered essential, it should be administered carefully): For patients with abnormal clinical laboratory values related to renal function, co-administration with fibrates should not be undertaken except when that co-administration is considered essential. [Rhabdomyolysis is more likely to occur.] (See Interactions.)